CareMax, Inc., a health care organization, provides medical services through physicians and health care professionals. The company offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health & wellness, optometry, dental, pharmacy and transportation. As of June 30, 2021, it owned and operated 36 multi-specialty medical care centers throughout Miami-Dade, Broward, and Orange Counties in Florida. The company is headquartered in Miami, Florida.
IPO Year: 2020
Exchange: NASDAQ
Website: caremax.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2024 | $1.50 → $7.50 | Buy → Hold | Jefferies |
| 11/17/2023 | $5.00 → $1.00 | Buy → Neutral | UBS |
| 11/10/2023 | $3.00 → $2.00 | Overweight → Neutral | Piper Sandler |
| 3/17/2023 | $7.00 → $4.00 | Outperform → Market Perform | TD Cowen |
| 9/7/2022 | $7.50 | Hold | Truist |
| 1/7/2022 | $14.00 | Buy | UBS |
| 10/20/2021 | $15.00 | Buy | Jefferies |
| 9/13/2021 | $14.00 | Neutral → Overweight | Piper Sandler |
| 9/13/2021 | Neutral → Overweight | Piper Sandler | |
| 9/10/2021 | $14.00 | Outperform | Cowen & Co. |
Steward Health Care, the nation's largest physician-led health care network, today announced the appointment of Rubén José King-Shaw Jr to its Board of Directors. King-Shaw currently serves as Steward's Executive Vice President & Chief Strategy Officer, where he has led a number of critical strategic acquisitions and divestitures including the sale of Steward Health Choice Arizona and the significant merger of Steward's value-based Medicare business with Caremax (NASDAQ:CMAX). King-Shaw also chairs Steward's offshore captive insurance company, TRACO, which is domiciled in Panamá. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced the appointment of Mr. Jose R. Rodriguez as Chair of CareMax's board of directors, to succeed Mr. Richard A. Barasch, who has resigned from the Board. Mr. Rodriguez has served as a member of CareMax's board of directors since June 2021 and previously served as CareMax's Lead Independent Director. Mr. Barasch will continue to serve as an advisor to CareMax's board of directors. "We are excited that Jose has agreed to lead CareMax's board of directors as we start our first full year as a public company. The board and I believe Jose's recognized leadership in
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced that Beatriz Assapimonwait has been appointed as an independent member of the CareMax board of directors. Ms. Assapimonwait brings to CareMax 38 years of Medicare managed care experience, including a decade of experience as a leader in the Medicare markets in South Florida, North Florida, and Puerto Rico. Most recently, Ms. Assapimonwait served as the Regional President for Humana South Florida where she was responsible for developing market strategies and leading market operations. Before that, Ms. Assapimonwait was CEO of Family Physicians of Winter Park
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced that Dr. Vincent Omachonu has been appointed as an independent member of the CareMax board of directors. "We are very pleased to have Dr. Omachonu join our board of healthcare industry veterans," said Carlos de Solo, CEO of CareMax. "Dr. Omachonu has extensive expertise in managed care and process improvement, and has helped to create replicable and measurable workflows in the industry, resulting in better patient experience and outcomes. We look forward to leveraging Dr. Omachonu's expertise as we work to bring CareMax's value-based model nationwide." Dr
3 - CareMax, Inc. (0001813914) (Issuer)
3 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
ClareMedica Health Partners to become "Stalking Horse" Bidder to Acquire CareMax's Core Centers' Assets CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that it has entered into a "stalking horse" purchase agreement with ClareMedica Health Partners ("ClareMedica"), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax's core centers' assets including a vast majority of CareMax's operating clinics (the "Core Centers' Assets"). The transaction will be implemented pursuant to a previously announced prearranged chapter 11 plan support
Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization
Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year Second Quarter Total Revenue of $198.6 million, down 12% year-over-year CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024. "Although our medical expense ratio continued to run higher than target levels, we were able to manage toward another quarter of sequential improvement in MER in the second quarter, and we continued to make progress against our clinical initiatives," said Carlos de Solo, Chief Executive Officer. Mr. de Solo continued, "Additiona
First Quarter Medicare Advantage Membership of 107,000, up 12% year-over-year First Quarter Total Revenue of $232.2 million, up 34% year-over-year Continuing to Explore Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the first quarter ended March 31, 2024. "During the first quarter of 2024, we believe we began to see benefits from our fourth quarter clinical efforts which became fully implemented toward the end of last year," said Carlos de Solo, Chief Executive Officer. "While
Met 2023 Guidance for Medicare Advantage Membership and Total Revenue Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. "In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business," said Carlos de Solo, C
CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that the Company's Board of Directors (the "Board") has approved a 1-for-30 reverse stock split (the "Reverse Stock Split") of its Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), that is expected to become effective on Wednesday, January 31, 2024 at 11:59 p.m. Eastern Time (the "Effective Time"). The Class A Common Stock will continue to trade on the Nasdaq Stock Market ("Nasdaq") under the symbol "CMAX" and is expected to begin trading on a split-adjusted basis commencing upon market open on February 1, 2024. The n
Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year Third Quarter Total Revenue of $201.8 million, up 28% year-over-year Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended September 30, 2023. "Tomorrow marks one year since the acquisition of our national MSO and nearly two and a half years of rapid growth in our patient and provider base. Over that period, we experienced fluctuations in o
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.caremax.com. About CareM
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 7:30 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations website at ir.caremax.com. About CareMax Founded in 2011, CareMax is a value-based care delivery system that utilizes a proprietary technology-enabled platform and multi-specialty, whole person health model to deliver com
Second Quarter Medicare Advantage Membership of 102,500, up 177% year-over-year Second Quarter Total Revenue of $224.4 million, up 30% year-over-year Raising Full Year 2023 Revenue Guidance; Reaffirming Full Year 2023 Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2023. "We continued to deliver on our growth strategy, ending the quarter with 102,500 Medicare Advantage members, up 177% year-over-year, and have confidence in achieving both our near and long-term membership targets that we announced at ou
Met 2023 Guidance for Medicare Advantage Membership and Total Revenue Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. "In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business," said Carlos de Solo, C
Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year Third Quarter Total Revenue of $201.8 million, up 28% year-over-year Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended September 30, 2023. "Tomorrow marks one year since the acquisition of our national MSO and nearly two and a half years of rapid growth in our patient and provider base. Over that period, we experienced fluctuations in o
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.caremax.com. About CareM
Second Quarter Medicare Advantage Membership of 102,500, up 177% year-over-year Second Quarter Total Revenue of $224.4 million, up 30% year-over-year Raising Full Year 2023 Revenue Guidance; Reaffirming Full Year 2023 Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2023. "We continued to deliver on our growth strategy, ending the quarter with 102,500 Medicare Advantage members, up 177% year-over-year, and have confidence in achieving both our near and long-term membership targets that we announced at ou
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the second quarter 2023 before the opening of the financial markets on Wednesday, August 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.
First Quarter Medicare Advantage Membership of 95,500, up 181% year-over-year First Quarter Total Revenue of $173.0 million, up 26% year-over-year Reaffirming Full Year 2023 Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the first quarter ended March 31, 2023. "We continued to execute on our national expansion strategy and delivered strong operational performance during the quarter. However, we had two prior period developments that had an unfavorable financial impact on our first quarter results. Looking ahead, we're encouraged by our run-rates for r
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the first quarter 2023 before the opening of the financial markets on Wednesday, May 10, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.car
Exceeded 2022 Guidance for Membership and Revenue and Met 2022 Guidance for Adjusted EBITDA (Inclusive of De Novo Pre-Opening Costs and Post-Opening Losses) Year-end 2022 Medicare Advantage Membership of 93,500, up 179% year-over-year Full Year 2022 Total Revenue of $631 million, up 113% year-over-year on a GAAP Basis, or up 57% on a Pro Forma Basis1,3 Expanded Presence with De Novo Openings in New York, Tennessee, Texas and Florida, Bringing Year-End Center Count to 62 Guided to Continued Growth in Medicare Advantage Membership, Revenue and Adjusted EBITDA in 2023 Increased Delayed Draw Term Loan Capacity on Existing Credit Facility by $60 million CareMax Scheduled to Host In
The Company will also report fourth quarter and full year 2022 results on March 9 CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, announced today that it will host an Investor Day for analysts and investors in Miami on Monday, March 13, 2023, beginning at 9:00 am Eastern Time. Registration is required to attend the event in-person. To register, please visit CareMax's Investor Day website. During the investor event, CareMax's executive leadership team will discuss the Company's strategic priorities, growth strategy, and financial outlook. Presentations will be followed by a live Q&A session. A live webcast of the Inves
Third Quarter 2022 Medicare Advantage Membership of 39,500, up 49% year-over-year Third Quarter 2022 GAAP Total Revenue of $157.7 million, up 51% year-over-year Expanded Presence with De Novo Openings in Brooklyn, New York; Queens, New York; and Plantation, Florida Since Quarter End Raising Full Year 2022 Revenue Guidance; Excludes Expected Impact from Steward Acquisition CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled provider of value-based care to seniors, today announced financial results for the third quarter ended September 30, 2022. "Our solid third quarter results are a testament to our focus on executing our strategy, operat
SC 13G/A - CareMax, Inc. (0001813914) (Subject)
SC 13G - CareMax, Inc. (0001813914) (Subject)
SC 13D/A - CareMax, Inc. (0001813914) (Subject)
SC 13G/A - CareMax, Inc. (0001813914) (Subject)
SC 13D/A - CareMax, Inc. (0001813914) (Subject)
SC 13D/A - CareMax, Inc. (0001813914) (Subject)
SC 13D/A - CareMax, Inc. (0001813914) (Subject)
SC 13G - CareMax, Inc. (0001813914) (Subject)
SC 13G - CareMax, Inc. (0001813914) (Subject)
SC 13G/A - CareMax, Inc. (0001813914) (Subject)
Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously
UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously
Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously
TD Cowen downgraded CareMax from Outperform to Market Perform and set a new price target of $4.00 from $7.00 previously
Truist initiated coverage of CareMax with a rating of Hold and set a new price target of $7.50
UBS initiated coverage of CareMax with a rating of Buy and set a new price target of $14.00
Jefferies initiated coverage of CareMax with a rating of Buy and set a new price target of $15.00
Piper Sandler upgraded CareMax from Neutral to Overweight and set a new price target of $14.00
Piper Sandler upgraded CareMax from Neutral to Overweight
Cowen & Co. initiated coverage of CareMax with a rating of Outperform and set a new price target of $14.00
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
NT 10-Q - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)